
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Discover essential guidelines for complying with the Drug Supply Chain Security Act (DSCSA). Learn how to enhance supply chain security and meet regulatory standards across various roles in the pharmaceutical industry.






